US 8063084
Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels
granted A61PA61P1/14A61P1/16
Quick answer
US patent 8063084 (Heterocyclic compounds suitable for the treatment of diseases related to elevated lipid levels) held by Xenon Pharmaceuticals Inc. expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Xenon Pharmaceuticals Inc.
- Grant date
- Tue Nov 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P1/14, A61P1/16, A61P1/18, A61P11/06